Cryptogenic Cirrhosis and Sitosterolemia:

A Treatable Disease If Identified but Fatal If Missed 

Autores: Bazerbachi Fateh, Conboy Erin E, Mounajjed Taofic, Watt Kymberly D, Babovic Vuksanovic Dusica, Patel Shailendra B, Kamath Patrick S

Resumen

Sitosterolemia is an autosomal recessive metabolic disease caused by mutations in ABCG5 or ABCG8 genes which encode for the (ATP)-binding cassette (ABC) transporters that are responsible for the trafficking of xenosterols. Liver involvement is not a recognized manifestation of this disease, and cirrhosis has been reported only once in the medical literature. We describe a fatal case of a 21-year old South Asian male who presented with decompensated cirrhosis, and biochemical abnormalities consistent with sitosterolemia. Genetic testing showed a homozygous pathogenic mutation in ABCG5, confirming the diagnosis. Sitosterolemia is a rare, but likely under-recognized condition, and a high degree of suspicion is imperative to make the diagnosis. We propose that sitosterolemia should be included in the differential diagnosis for patients with cryptogenic cirrhosis, especially as there are effective oral therapies to treat this condition. Newly diagnosed sitosterolemia patients should undergo a thorough hepatology evaluation and follow-up to evaluate for the presence, development, and progression of any hepatic involvement.

Palabras clave: Cryptogenic cirrhosis ascites idiopathic cirrhosis sitosterolemia phytosterolemia. plant sterols premature coronary artery disease macrothrombocytopenia ABCG5. ABCG8.

2017-12-13   |   312 visitas   |   1 valoraciones

Vol. 16 Núm.6. Noviembre-Diciembre 2017 Pags. 970-978 Ann Hepatol 2017; 16(6)